Involvement of IL-1 and oncostatin M in acanthosis associated with hypertensive leg ulcer

American Journal of Pathology

Volumn 182, Issue 3, 2013, Pages 806-818

  Giot, Jean Philippe ^a,b   Paris, Isabelle ^a   Levillain, Pierre ^b   Huguier, Vincent ^a,b   Charreau, Sandrine ^a   Delwail, Adrianna ^a   Garcia, Martine ^a   Garnier, Julien ^c   Bernard, François Xavier ^a,c   Dagregorio, Guy ^a,b   Guillet, Gérard ^a,b   Morel, Franck ^a   Lecron, Jean Claude ^a,b   Favot, Laure ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c BIOalternatives ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; ONCOSTATIN M;

ACANTHOSIS; AGED; ARTICLE; CLINICAL ARTICLE; DERMIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY CELL; LEG HYPERTENSIVE ULCER; LEG ULCER; MACROPHAGE; MALE; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE; TH17 CELL;

ADULT; AGED; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONSTRICTION, PATHOLOGIC; EPIDERMIS; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-1BETA; INTERLEUKIN-6; KERATIN-10; KERATINOCYTES; KI-67 ANTIGEN; LEG ULCER; LEUKOCYTES; MALE; MELANOSIS; MICE; MICE, INBRED C57BL; MICROVESSELS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ONCOSTATIN M;

EID: 84874542284     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.11.030     Document Type: Article

References (43)

1. E.A. Hines, and E.M. Farber Ulcer of the leg due to arteriosclerosis and ischemia occurring in the presence of hypertensive disease (hypertensive ischemic ulcer): a preliminary report Proc Annu Meet Cent Soc Clin Res U S 21 1946 337 346
2. F. Martorell Las ulceras supramaleolares por arteriolitis de las grandes hipertensas Actas del Instituto Policlinico de Barcelona 1 1945 3
3. D. Colomb, E. Lejeune, J.N. Bertrand, M. Bouvier, and M. Bochu [Necrotic Angiodermatitis of the Gangrenous Superficial Plaque Type. Combined Role of an Atherosclerotic Local Terrain and General Terrain] French Bull Soc Fr Dermatol Syphiligr 70 1963 945 946
4. K. Nikolova Treatment of hypertensive venous leg ulcers with nifedipine Methods Find Exp Clin Pharmacol 17 1995 545 549
5. H.J. Leu Hypertensive ischemic leg ulcer (Martorell's ulcer): a specific disease entity? Int Angiol 11 1992 132 136
6. J.F. Merlen [Necrotic angiodermatitis] French J Mal Vasc 8 1983 73 75
7. I. Lazareth, and P. Priollet [Necrotic angiodermatitis: treatment by early cutaneous grafts] French Ann Dermatol Venereol 122 1995 575 578
8. G. Dagregorio, and G. Guillet A retrospective review of 20 hypertensive leg ulcers treated with mesh skin grafts J Eur Acad Dermatol Venereol 20 2006 166 169
9. H.J. Duncan, and I.B. Faris Martorell's hypertensive ischemic leg ulcers are secondary to an increase in the local vascular resistance J Vasc Surg 2 1985 581 584
10. C.A. Henderson, A.S. Highet, S.A. Lane, and R. Hall Arterial hypertension causing leg ulcers Clin Exp Dermatol 20 1995 107 114
11. N.J. Wilson, K. Boniface, J.R. Chan, B.S. McKenzie, W.M. Blumenschein, J.D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, J.C. Lecron, R.A. Kastelein, D.J. Cua, T.K. McClanahan, E.P. Bowman, and R. de Waal Malefyt Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 2007 950 957
12. K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger, E. Ravon, M. Garcia, E. Venereau, L. Preisser, E. Guignouard, G. Guillet, G. Dagregorio, J. Pene, J.P. Moles, H. Yssel, S. Chevalier, F.X. Bernard, H. Gascan, and J.C. Lecron Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation J Immunol 178 2007 4615 4622
13. K. Boniface, F.X. Bernard, M. Garcia, A.L. Gurney, J.C. Lecron, and F. Morel IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes J Immunol 174 2005 3695 3702
14. K. Guilloteau, I. Paris, N. Pedretti, K. Boniface, F. Juchaux, V. Huguier, G. Guillet, F.X. Bernard, J.C. Lecron, and F. Morel Skin inflammation induced by the synergistic action of IL-17A. IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis J Immunol 184 2010 5263 5270
15. H. Koyama, E.W. Raines, K.E. Bornfeldt, J.M. Roberts, and R. Ross Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors Cell 87 1996 1069 1078
16. E.W. Raines, S.K. Dower, and R. Ross Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA Science 243 1989 393 396
17. E.W. Raines, H. Koyama, and N.O. Carragher The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF Ann N Y Acad Sci 902 2000 39 51 discussion 51-32
18. C.N. Chen, Y.S. Li, Y.T. Yeh, P.L. Lee, S. Usami, S. Chien, and J.J. Chiu Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells Proc Natl Acad Sci U S A 103 2006 2665 2670
19. H. Loppnow, and P. Libby Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6 J Clin Invest 85 1990 731 738
20. K. Norioka, M. Hara, M. Harigai, A. Kitani, T. Hirose, W. Hirose, K. Suzuki, M. Kawakami, M. Kawagoe, and H. Nakamura Pretreatment of human vascular smooth muscle cells with interleukin-1 enhances interleukin-6 production and cell proliferation (action of IL-1 on vascular smooth muscle cells) Autoimmunity 7 1990 41 50
21. P. Libby, S.J. Warner, and G.B. Friedman Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids J Clin Invest 81 1988 487 498
22. K. Schultz, V. Murthy, J.B. Tatro, and D. Beasley Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol 292 2007 H2927 H2934
23. S. Demyanets, C. Kaun, K. Rychli, G. Rega, S. Pfaffenberger, T. Afonyushkin, V.N. Bochkov, G. Maurer, K. Huber, and J. Wojta The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways Am J Physiol Heart Circ Physiol 293 2007 H1962 H1968
24. R.I. Grove, C. Eberhardt, S. Abid, C. Mazzucco, J. Liu, P. Kiener, G. Todaro, and M. Shoyab Oncostatin M is a mitogen for rabbit vascular smooth muscle cells Proc Natl Acad Sci U S A 90 1993 823 827
25. A. Albasanz-Puig, J. Murray, M. Preusch, D. Coan, M. Namekata, Y. Patel, Z.M. Dong, M.E. Rosenfeld, and E.S. Wijelath Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis Atherosclerosis 216 2011 292 298
26. M. Rosdy, B. Bertino, V. Butet, S. Gibbs, M. Ponec, and M. Darmon Retinoic acid inhibits epidermal differentiation when applied topically on the stratum corneum of epidermis formed in vitro by human keratinocytes grown on defined medium In Vitro Toxicol 10 1997 39 47
27. P. Zukervar, and D. Colomb [Necrotic atheromatous angiodermatitis of the legs] French Phlebologie 43 1990 469 472 discussion 472-465
28. L. Guillevin [Systemic diseases and ulceronecrotic angiodermatitis] French Phlebologie 37 1984 341 345
29. D. Colomb, and F. Vittori [Arteriosclerotic necrotic angiodermatitis of the lower limbs. Anatomo-clinical study, apropos of 34 cases] French Ann Dermatol Syphiligr (Paris) 101 1974 15 32
30. K. Wolk, K. Warszawska, C. Hoeflich, E. Witte, S. Schneider-Burrus, K. Witte, S. Kunz, A. Buss, H.J. Roewert, M. Krause, A. Lukowsky, H.D. Volk, W. Sterry, and R. Sabat Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa J Immunol 186 2011 1228 1239
31. P. Corbi, M. Rahmati, A. Delwail, D. Potreau, P. Menu, J. Wijdenes, and J.C. Lecron Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation Eur J Cardiothorac Surg 18 2000 98 103
32. A.W. Orr, N.E. Hastings, B.R. Blackman, and B.R. Wamhoff Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis J Vasc Res 47 2010 168 180
33. P.R. Taylor, L. Martinez-Pomares, M. Stacey, H.H. Lin, G.D. Brown, and S. Gordon Macrophage receptors and immune recognition Annu Rev Immunol 23 2005 901 944
34. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147
35. K. Boniface, E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F.X. Bernard, F. Nau, G. Guillet, G. Dagregorio, H. Yssel, J.C. Lecron, and F. Morel A role for T cell-derived interleukin 22 in psoriatic skin inflammation Clin Exp Immunol 150 2007 407 415
36. H.H. van der Zee, L. de Ruiter, D.G. van den Broecke, W.A. Dik, J.D. Laman, and E.P. Prens Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta Br J Dermatol 164 2011 1292 1298
37. R.M. Grossman, J. Krueger, D. Yourish, A. Granelli-Piperno, D.P. Murphy, L.T. May, T.S. Kupper, P.B. Sehgal, and A.B. Gottlieb Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes Proc Natl Acad Sci U S A 86 1989 6367 6371
38. T. Bourcier, M. Dockter, and A. Hassid Synergistic interaction of interleukin-1 beta and growth factors in primary cultures of rat aortic smooth muscle cells J Cell Physiol 164 1995 644 657
39. S. Demyanets, C. Kaun, K. Rychli, S. Pfaffenberger, S.P. Kastl, P.J. Hohensinner, G. Rega, K.M. Katsaros, T. Afonyushkin, V.N. Bochkov, M. Paireder, I. Huk, G. Maurer, K. Huber, and J. Wojta Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-gamma Basic Res Cardiol 106 2011 217 231
40. T. Kubin, J. Poling, S. Kostin, P. Gajawada, S. Hein, W. Rees, A. Wietelmann, M. Tanaka, H. Lorchner, S. Schimanski, M. Szibor, H. Warnecke, and T. Braun Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling Cell Stem Cell 9 2011 420 432
41. M. Kawaguchi, M. Takahashi, T. Hata, Y. Kashima, F. Usui, H. Morimoto, A. Izawa, Y. Takahashi, J. Masumoto, J. Koyama, M. Hongo, T. Noda, J. Nakayama, J. Sagara, S. Taniguchi, and U. Ikeda Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury Circulation 123 2011 594 604
42. Z. Li, H. Wei, L. Deng, X. Cong, and X. Chen Expression and secretion of interleukin-1beta, tumour necrosis factor-alpha and interleukin-10 by hypoxia- and serum-deprivation-stimulated mesenchymal stem cells FEBS J 277 2010 3688 3698
43. C.A. Dinarello A clinical perspective of IL-1beta as the gatekeeper of inflammation Eur J Immunol 41 2011 1203 1217